Krónikus vesebetegség: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• SGLT2 24
• GLP-1 8
• NLRP3 0
• NRF2 1
• PI3K 0
• APOL1 3
• STAT3 1
• AKT 0
• mTOR 1
• PPAR 0
• AMPK 0
• SIRT1 0
• HIF-1 0
• TLR4 0
• MAPK 0
• STING 0
• CTNNB1 0
• TP53 0
• ERK 0
• GPX4 0
• IL-6 3
• VEGF 0
• JAK 0
• IL-1 1
• JNK 0
• TNF 1
• DPP-4 0
• EGFR 0
• YAP 0
• FGFR 0
• PCSK9 0
• APOE 0
• PINK1 0
• TFEB 0
• BCMA 3
• HMGB1 0
• HSP90 0
• BDNF 0
• GIP 0
• CD40 0
• CD47 0
• COX-2 0
• IL-17 1
• PKM2 0
• PSMA 0
• ABL1 0
• CCR5 0
• EZH2 0
• METTL3 0
• MMP-9 0
• PKD1 0
• PTEN 0
• SNCA 0
• ANGPTL3 0
• BCL-2 0
• CD19 1
• CD38 0
• CDK4/6 0
• CXCR4 0
• FTO 0

3+ intézményből 3, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NEI · R01

  Mobile Strategy for Improving Eye Health of Kidney Patients Treated with Dialysis (SIGHT)

  University of Washington· Seattle, Egyesült Államok· 1 383 760 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIDDK · K08

  Natural killer T cells in acute cardiorenal syndrome

  Oregon Health & Science University· Portland, Egyesült Államok· 160 584 USD awarded in fiscal year 2026· until 2031. júl.

• NIH NIA · R43

  Optimization of brain-permeable CK2 inhibitors to inhibit neuroinflammation and metabolic dysfunction in Alzheimer's disease

  Talos Therapeutics, Inc.· San Diego, Egyesült Államok· 497 554 USD awarded in fiscal year 2026· until 2027. szept.

• NIH NIDDK · R01

  The Interaction between Food Craving and Food Choice in Humans: A Computational Intracranial Electrophysiological Study

  Icahn School of Medicine at Mount Sinai· New York, Egyesült Államok· 854 983 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIDDK · R01

  mRNA Splicing in Podocyte Biology and Glomerular Disease

  State University New York Stony Brook· Stony Brook, Egyesült Államok· 755 725 USD awarded in fiscal year 2026· until 2030. jún.

• European Commission (Horizon Europe) · HORIZON-ERC

  Deciphering the gene regulation of oxygen homeostasis and human fitness (ErythrO2Reg)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 500 000 EUR· until 2032. márc.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Next-generation therapeutics for vascular diseases (TIE2gether)

  Helsingin Yliopisto· Helsinki, Finnország· EU contribution 4 273 568 EUR· until 2031. jan.· 7 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Formaldehyde crosslink exposure and genomic ageing (FORCE)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, Egyesült Királyság· EU contribution 2 693 628 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Early Inflammation in Fibrotic Niches of Chonic Kidney Disease (InFibrosis)

  Universite Paris Cite· Paris, Franciaország· EU contribution 1 498 100 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Direct implication of the Calcium Sensing Receptor in Vascular Calcifiction and Atherosclerosis in Chronic Kidney Disease (AtheroCaSR)

  Cardiff University· Cardiff, Egyesült Királyság· EU contribution 325 435 EUR· until 2029. febr.

10 of 1568 running projects, newest first. Listed amounts together: 854,3 M USD + 145,3 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

  NCT05092347· Regeneron Pharmaceuticals· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 29
• Organoids 10
• Mendelian Randomization Analysis 78
• CRISPR-Cas Systems 5
• Gene Expression Profiling 88
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 2
• Exome Sequencing 19
• Proteomics 103
• Metabolomics 91
• Mass Spectrometry 18
• Flow Cytometry 10
• Immunohistochemistry 19
• Liquid Biopsy 2
• Positron-Emission Tomography 5
• Magnetic Resonance Imaging 70
• Machine Learning 176
• Deep Learning 23
• Cohort Studies 556
• Genome-Wide Association Study 79

• Detection of the NPHP4 c.2999_3005del (p.Asn1000SerfsTer4) variant in an Iranian family with nephronophthisis-4.

  Mol Genet Genomics, 2026. júl.

• Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders.

  Eur J Hum Genet, 2026. jún.

• Monogenic kidney disease and monogenic diabetes are present in renal clinic patients with non-genetic diagnoses.

  Sci Rep, 2026. máj.

• Clinical and Molecular characteristics of kidney and urinary tract congenital anomalies in a cohort of Egyptian patients using whole-exome sequencing.

  Mol Biol Rep, 2026. máj.

• A Whole-Exome Sequencing-Based Exploration of Chronic Kidney Disease of Unknown Etiology (CKDu) in an Endemic Population in Sri Lanka.

  Int J Mol Sci, 2026. ápr.

• Prevalence and Genetic Spectrum of Inherited Kidney Diseases: A Chinese Cohort Study.

  Kidney360, 2026. ápr.

• Genetic testing in kidney transplantation and living kidney donor risk assessment.

  Kidney Int, 2026. márc.

• FREM2 as a candidate gene for posterior urethral valves: Evidence from a case-parent cohort.

  J Pediatr Urol, 2026. márc.

• Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.

  Hum Genomics, 2026. márc.

• Early-onset kidney failure in a girl with autosomal dominant tubulointerstitial kidney disease due to a de novo UMOD variant.

  CEN Case Rep, 2026. febr.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.